- Home
- / Aurisco Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Aurisco Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥22.9
2024-10-29
Market Capitalization
¥9.1 B
2024-10-29
Revenue
¥1.7 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 569.2M | 576.0M | 711.7M | 793.6M | 993.2M | 1.2B | 1.5B | 1.7B |
| Cost of goods sold | 304.6M | 283.3M | 380.5M | 408.6M | 487.7M | 556.6M | 611.5M | 684.6M |
| Gross profit | 264.8M | 293.2M | 334.8M | 387.9M | 512.8M | 696.1M | 854.3M | 997.1M |
| Gross profit margin, % | 46.5% | 50.9% | 47.0% | 48.9% | 51.6% | 56.0% | 58.4% | 59.6% |
| Operating expense total | 89.9M | 75.8M | 109.6M | 153.9M | 227.6M | 333.2M | 364.4M | 331.3M |
| Depreciation and amortization | 22.2M | 53.2M | 32.0M | 51.5M | 64.9M | 74.2M | 82.7M | 119.3M |
| EBITDA | 174.9M | 217.4M | 225.2M | 234.0M | 285.2M | 362.9M | 489.9M | 665.7M |
| EBITDA margin, % | 30.7% | 37.7% | 31.6% | 29.5% | 28.7% | 29.2% | 33.5% | 39.8% |
| EBIT | 161.1M | 202.1M | 195.7M | 191.7M | 214.3M | 280.9M | 387.6M | 543.8M |
| EBIT margin, % | 28.3% | 35.1% | 27.5% | 24.2% | 21.6% | 22.6% | 26.5% | 32.5% |
| Interest income | 1.1M | 2.1M | 5.5M | 8.3M | 4.4M | 16.5M | 14.9M | 13.4M |
| Interest expense | 3.0K | 1.0M | 2.7M | 15.8M | 34.7M | |||
| Pre tax profit | 164.2M | 206.3M | 185.7M | 192.0M | 240.8M | 329.1M | 407.4M | 518.3M |
| Income tax expense | 27.4M | 20.2M | 28.5M | 23.7M | 32.5M | 40.0M | 52.6M | 69.1M |
| Net Income | 136.8M | 186.1M | 157.2M | 168.3M | 208.3M | 289.1M | 354.8M | 449.2M |